[company_age]10.0[/company_age][employees]2-10 employees[/employees][funding]Series B[/funding][description]Enterprise Therapeutics is a drug discovery company focused on developing novel therapies for respiratory diseases. They aim to improve the lives of patients suffering from conditions like cystic fibrosis, asthma, and COPD by targeting the underlying mechanisms of mucus congestion. Their leadership team boasts extensive experience in drug discovery, development, respiratory biology, and ion channel pharmacology. Additionally, the company collaborates closely with the University of Sussex's School of Life Sciences, providing them with access to cutting-edge research and expertise.[/description][ps]Novel therapies for respiratory diseases[/ps]